nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adipocytes impair efficacy of antiretroviral therapy
|
Couturier, Jacob |
|
|
154 |
C |
p. 140-148 |
artikel |
2 |
A Guinea pig cytomegalovirus resistant to the DNA maturation inhibitor BDCRB
|
Ourahmane, Amine |
|
|
154 |
C |
p. 44-50 |
artikel |
3 |
An in silico-designed flavone derivative, 6-fluoro-4′-hydroxy-3′,5′-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells
|
Fujimoto, Kazuhiro J. |
|
|
154 |
C |
p. 10-16 |
artikel |
4 |
Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model
|
Caidi, Hayat |
|
|
154 |
C |
p. 149-157 |
artikel |
5 |
A tetravalent vaccine comprising hexon-chimeric adenoviruses elicits balanced protective immunity against human adenovirus types 3, 7, 14 and 55
|
Tian, Xingui |
|
|
154 |
C |
p. 17-25 |
artikel |
6 |
BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo
|
Morse, Mary A. |
|
|
154 |
C |
p. 158-165 |
artikel |
7 |
Caffeic acid inhibits HCV replication via induction of IFNα antiviral response through p62-mediated Keap1/Nrf2 signaling pathway
|
Shen, Jian |
|
|
154 |
C |
p. 166-173 |
artikel |
8 |
Editorial Board
|
|
|
|
154 |
C |
p. ii |
artikel |
9 |
Hepatitis B virus rtA181T/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T/sW172* mutation
|
Zhao, Li |
|
|
154 |
C |
p. 26-34 |
artikel |
10 |
Human monoclonal antibodies against West Nile virus from Japanese encephalitis-vaccinated volunteers
|
Ozawa, Tatsuhiko |
|
|
154 |
C |
p. 58-65 |
artikel |
11 |
Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme
|
Feibelman, Kristen M. |
|
|
154 |
C |
p. 124-131 |
artikel |
12 |
Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses
|
Tu, Véronique |
|
|
154 |
C |
p. 110-115 |
artikel |
13 |
Inhibition of dengue virus infection by mannoside glycolipid conjugates
|
Schaeffer, Evelyne |
|
|
154 |
C |
p. 116-123 |
artikel |
14 |
Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection
|
Qu, Panke |
|
|
154 |
C |
p. 97-103 |
artikel |
15 |
ISAR News
|
|
|
|
154 |
C |
p. e1-e17 |
artikel |
16 |
Luteolin escape mutants of dengue virus map to prM and NS2B and reveal viral plasticity during maturation
|
Peng, Minhua |
|
|
154 |
C |
p. 87-96 |
artikel |
17 |
Novel activities of safe-in-human broad-spectrum antiviral agents
|
Ianevski, Aleksandr |
|
|
154 |
C |
p. 174-182 |
artikel |
18 |
Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus
|
Anindita, Paulina D. |
|
|
154 |
C |
p. 1-9 |
artikel |
19 |
Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system
|
Jiang, Wang |
|
|
154 |
C |
p. 51-57 |
artikel |
20 |
Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008
|
Milligan, Gregg N. |
|
|
154 |
C |
p. 104-109 |
artikel |
21 |
Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014–2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile
|
Matos, Aline R. |
|
|
154 |
C |
p. 35-43 |
artikel |
22 |
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
|
Seley-Radtke, Katherine L. |
|
|
154 |
C |
p. 66-86 |
artikel |
23 |
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
|
Calvo-Pinilla, Eva |
|
|
154 |
C |
p. 132-139 |
artikel |